Skip to main content
Joyce Wald, DO, Cardiology, Philadelphia, PA

Joyce W Wald DO

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Interventional Cardiology


Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile
  • 3400 Civic Center BlvdEast Pavilion, 2nd FloorPhiladelphia, PA 19140

  • Phone+1 215-615-0800

  • Fax+1 215-615-0829

Dr. Wald is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Temple University Hospital
    Temple University HospitalFellowship, Cardiovascular Disease, 1996 - 1999
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1993 - 1996
  • Philadelphia College of Osteopathic Medicine
    Philadelphia College of Osteopathic MedicineClass of 1992

Certifications & Licensure

  • PA State Medical License
    PA State License 1995 - 2026
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
    Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25March 27th, 2025
  • Experts Hash Out Recommendations for Impella CP After DanGer Shock
    Experts Hash Out Recommendations for Impella CP After DanGer ShockFebruary 14th, 2025
  • Benefits of COVID-19 Vaccination Outweigh the Rare Risk of Myocarditis, Even in Young Males
    Benefits of COVID-19 Vaccination Outweigh the Rare Risk of Myocarditis, Even in Young MalesMarch 2nd, 2022

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: